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Although modern science and technology has made transplantation of organs
more successful now then in the past, sadly, many people each year die waiting
for donor organs.
There are a variety of reasons why not everyone who needs an organ
can receive one, even when it is available. Pre-existing medical problems, risk of
rejection, advanced age, and high cost of the procedure itself are only a few
reasons that keep the dying patient waiting. However, the most common cause
of the long wait is organ availability.
What limits the availability of these organs? Basically, people fear
becoming donors, if they do make that decision, often they fail to communicate
that wish to their families. The consent of the family at the time of the donors
demise contributes to this scarcity.
Ravaging diseases people encounter will certainly be fatal to many
without an organ replacement. Diabetes is one of the most severe diseases,
it virtually attacks, the entire body. Kidney failure is another, it keeps a patient on
dialysis to filter out the toxins from their blood, the only way of surviving while
awaiting a donor organ. Everyone on dialysis is a also a candidate.
Other barriers exist, such as waiting for the proper donor. Both donor and
recipient have to match compatibly in tissue typing and blood type. Even with the
aid of computers to do the matching, risk of rejections still remains a reality.
Only an organ from an identical twin assures an exact match.
Despite the odds, survivability of recipients have made great strides over
the decades. Immunosuppressant drugs have made that a reality. Yet, the
sad truth remains, many will die waiting, unless there are more organ donors
to save their lives.
Lila Pummer-Verte
JAMA
The Journal of theAmerican Medical Association
February 1, 1995
Transplants are more successful now, bbtinafiydie waiting.
NOMENCLATURE BASED ON RELATIONSHIP BETWEEN DONOR AND RECIPIENT












Donor and recipient of same species and
identical genotype
Donor and recipient of same species but
different genotype
Donor and recipient of different species






Transplanted tissue or organ placed in an
anatomically normal site for that particular
tissue or organ.
Transplanted tissue or organ placed in an
anatomically abnormal site for that
particular tissue or organ.
Graft is in addition to the recipients
own organ.
NOMENCLATURE BASED ON TECHNIQUE OF GRAFTING
Free graft Transplanted tissue is completely detached from
the donor and there are no vascular anastomosis
between graft and recipient created by the
surgeon.
Pedicle graft Graft is initially attached to its site of origin by
a vascular pedicle which is subsequently severed when
the graft has developed vascular connections at the
new site.
Graft with vascular anastomoses Graft is completely detached from donor and vascular
anastomoses between graft and recipient are created
by the surgeon at the time of transplantation.
Chapter 1
ATTITUDES TOWARD ORGAN DONATION AND TRANSPLANTATION
In order to understand the reactions to medical procedures after death, it is
necessary to reach a deeper understanding of the factors that influence the
attitudes toward organ donations and other procedures with the decreased body.
In 1994, a survey was taken from 400 inhabitants of a city in the middle
of Sweden. The survey was concerned with attitudes toward transplantation
issues. From the interviews, motive complexes were analyzed and interpreted.
The motives were divided into these complexes:
(1) Illusion of lingering life. (2) Protections of the value of the individual;
(3) Distrust, anxiety and alienations; (4) Respecting the limits set by Nature
or God ; (5) Altruism; and (6) Rationality.
The individuals that were determined as not willing to donate their own
organs were either reacting out of death anxiety defenses, or had a special
outlook on life, one that included emphasis on the idea of what was natural .
The adverse reactions of the positive group dealt with more initial reactions
such as those which were weakened upon confrontation with the subject,
or altruistic and fact-stressing arguments.
The Motive Categories
1 . Uneasiness at the thought of cutting the dead body. These reactions
included attitudes which applied to autopsy. The thought of the body being
damaged and destroyed.
2. Anxiety about not keeping the dead body intact. The desire to keep the
dead body whole, i.e; that nothing is being removed from it, and a feeling of
invasion of private property.
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3. Discomfort with donations of certain organs. The expression that certain
organs were more important than others especially the eyes, or heart, therefore
making them more difficult to donate than others. They were expressed as
having symbolic meaning.
4. Difficulty with cutting into children. The fact that ones own children are felt
to be part of oneself, and not yet fully developed, made this particularly difficult
as the child's organs were viewed as being precious possessions.
5. Fear of destruction. These feelings were associated with being deprived
of human characteristics. Concerns about what becomes of the body after death,
either with decomposure or consumed by fire are also brought into this category.
6. Uneasiness with exposure. Opposition to the knowledge that the body would
be uncovered, exposed to the view of others and revealed.
7. Fear of disrespect for the dead person. The main consensus of opinion was to
leave the dead alone and let the body rest in peace, incisions and operations on a
corpse were in fact disrespectful and disgraceful. It was considered important in
this case to view the body as an individual , not just an object providing organs.
8. Anxiety about offending the family. This conception was mostly concerned with
the consideration of the feelings of the family, the difficulty in the knowledge of a
member being cut up and his or her organs being removed.
9. Discomfort with changes in appearance. It was important here about thinking
how the dead body would appear after the organ removal or autopsy, particularly a
fear that the deceased would not be recognized as the person he or she once was.
10. Apprehension about the funeral. It was important that the ceremony not be
delayed, marking the end of life in a traditional form, and in no way of being
offensive.
1 1 . Fear of obstacle to rebirth. Advocates fear giving away their organs they
would need in the next life, or knowledge that the body would be destroyed
by cremation or decomposition, feeling the body must remain intact as it was in
the moment of death if there was to be a resurrection involved.
12. Dislike of having one's organ surviving in another's body or having another's
organ living on in one's own body.
The insecurity some felt as the feeling of imaging one's organ living on
even though the person was dead. Concern was to be sure of one's whole
body dying at the same time.
13. Discomfort at giving useless organs. This was associated with a feeling of
shame, that one's organs would not be suitable for another's survival.
14. Problems with the concept of death. This category was faced with three
types of concerns: (a) A negative view of brain-related death, i.e, organs must not
be taken from a person with a still beating heart, (b) Concern with the brain dead
person still having pain sensations as well as fragments of consciousness remaining.
(c) The view that diagnostic methods used to pronounce death are not adequate
or people are being pronounced dead prematurely in order to get hold of their
organs. Mostly there was fear of pain during the procedure and even hope for
possible survival if one had not been chosen as a donor.
15. Distrust of the doctors. The notion that the individual wishes are not being
respected, rules being violated, and doctors who are too career oriented
exceeding their ethical limits.
Various explanations were offered as to the question why it was important that a
corpse be respected in a way that the person maybe never was. One explanation
was centered on the fear of the dead seeking revenge, or harm from the dead if
something is done to cause their disapproval. For example, giving away their
organs against their will. Another more common reaction was the need to protect
the individual's worth, this seemed to be connected with the fear of being
obliterated as an individual, and the need to protect their worth in society,
principally it was the idea with the illusion of symbolic survival.
Perhaps a more common explanation to these opinions is the thought that
during life the body and the self is experienced as being inseparable, and this
unity does not end abruptly when death occurs. The importance of the funeral act
and the burial are significant to this idea. These rites focus on the deceased and
his or her life. The belief in a disconnection from God or a divine power reflect
the helplessness, insecurity and alienation some people feel will happen once
they become transplant donors.
Why do some people feel transplant surgery does not respect the limits set by
Nature or God? Many persons feel they will not be themselves any longer, and if
they donate their organs they will become part of another persons personality in
some way. Another view is there needs to be a limit for the manipulations of
mankind and transplantation exceeds this limit. Man loses control over himself
when he chooses to rule over the natural forces, he in fact has no right to prolong
life. However, persons who make this statement do accept other kinds of
advanced medical care such as coronary by-pass surgery and pace-makers.
Although this seems illogical in reasoning, when viewing the difference between
transplantation surgery and other kinds of medical intervention, there seems
to be a special conception of what is natural and what is not.
Very few people in the negative motive complexes mentioned that
transplantation can help people to survive or be given a better quality of life.
Only a few not willing to donate saw it as an altruistic act. By contrast, people
in the positive motive complex groups were not only willing to donate their bodies
for dissection but expressed appreciation for those who would. Saving lives was
their chief motive, with total indifference to what would happen to the dead body.
They also saw the process as a sort of reciprocity for themselves in receiving help
if they were ever in need. The rationality behind the opinions formulated in the
positive group emphasized actual circumstances and facts concerned with their
reaction. These facts concluded: Dead persons cannot be hurt by procedures
after death, they do not feel or need anything. Sick and suffering people can
be saved by transplanted organs.
When comparing all the attitudes people had as a basis for the procedures
after death, they felt the dead do not feel or need anything. By contrast, sick and
suffering people can be saved by transplanted organs. When comparing all the
attitudes people had as a basis for the total value system or philosophy of life.
People who had the highest moral standards also had the most difficulty in their
decisions. In individuals who were undecided, lack of factual information played a
big role in the influence of their opinions. Among these people there was a genuine
causal relationship between knowledge of transplantation issues and the signing of
a donor card.
According to this study, there are certain misunderstandings of facts that
make people hesitant toward organ transplantation, mostly it is incorrect
information about death criteria. Persons in the negative group consisted of
people with increased death anxiety defenses, or with a special kind of life
philosophy. In these people there was little hope that they would be influenced by
knowledge of the correct facts concerning death. When evaluating decisions made
by people whose beliefs and motives took a strong stand concerning procedures
with the dead body, it was indicative of their misconceptions and discomfort in
thinking of the dead body being cut up. Their assumptions came from the fear of
being declared dead too soon, also that the organs would not be suitable as
transplants, religious beliefs were also a strong issue.
There is a need to better explore reactions connected with destruction.
It is probable that the motives in different age groups would also have different
reactions. A strong relationship between attitudes that were negative and age
were found to suggest a cohort phenomenon or effect of people's different
positions in the life cycle.
Better understanding regarding the concepts of death are necessary in
hope to influence attitudes involved in organ transplantation and inspire interest
in donation.
Chapter 2
THE HISTORY OF ORGAN TRANSPLANTATION
In America, Alexis Carrel was the first to experiment in early transplantation
by the transference of organs in animals. Carrel together with Emerick Ullmann
performed "en
masse"
transplantation by removing both kidneys, aorta,
and vena cava, taking the ureters with the kidneys for use in anastomosis.
Between 1900 and 1930, in this country and abroad, workers like Carrel and
Ullmann were performing this type of experiment. Kidneys were most often used
because of their simple vascular supply. The ureters functioned within minutes and
gave an index to work with. Although Carrel recognized the transferred kidneys
functioned normally, put out urine and maintained life, he was unaware what was
causing their loss. The concept of rejection was not yet understood.
The realization of rejection taking place was thought to be due to a process
quite distinct from infarction (ie., loss of arterial blood supply) infection, or
inflammation. Initially, the term rejection indicated a process by which the host
was not accepting of the new organ. It was not long before it was understood that
there might be some relationship involving the immunologic process by which an
organism combats invading bacterial infection.
In the mid 1920's Emile Holman, a surgeon of the Hopkins, Harvard, and
Stanford, carried out an experiment grafting skin from a mother onto her badly
burned child. The child not only rejected the mothers skin, he developed a severe
necrotizing inflammation of his own skin. This suggested shared antigens between
the child and his mother and the development of an autoimmune disease as the
cause of the necrotic dermatitis. Although the implications were evident, attempts
to study them further were not possible until early in 1951 when the group of
David Hume, George Thorn, and Gustave Dammin at the Peter Bent Brigham
Hospital in Boston got together to experiment with the grafting process. One
important aspect of the groups experience was their collaborative scientific work
involving medicine, surgery, pathology, radiology and immunology.
It was the forecast of the group collaboration which marked the efforts of many
institutions during the coming decades.
Skin Grafts
Actually the earliest record of autogenous pedicle grafts, used to restore mutila
tions of the nose, ear and lip were found in the Sanskrit of India, the Sushruta
Samhita, dated circa A.D. 450, which dates back several centuries before the
Christian era. Sushruta described the techniques of rhinoplasty and other
plastic procedures in his work which appeared to have evolved in response to the
social pressures encountered by the stigmata left by mutilations carried out in
punishment for crimes committed.
At the middle of the fifth century B.C., prior to Sushruta, Hippocratic
physicians gave similar emphasis of training and education in the development of
surgery and manipulative skills. However, Hippocrates was a practical man who
observed, judged, and developed procedures in theory, but there is no evidence
that he used free skin grafts, although he was evidently familiar with the methods
of repairing defects. The descendants of Hippocrates did however, understand and
employ repair of defects involving the nose, ear, lips and other body parts by
means of skin flaps. This documented technique is compiled in the De Medicina
(A.D. 14-37) and reflects the practices of the Greek School of medicine at
Alexandria during the latter part of the fourth and early part of the third
centuries B.C.
The practice of skin transplantation methods were also know to Galen (A.D.
131-201) and the tradition carried on by the Alexandrines, then latter followed by
Byzantine encyclopaedists (ca. 325-200 B.C.)
Transplantation of Organs
Considered the father of experimental surgery, John Hunter (1728-1793) applied
the principles of comparative anatomy thereby establishing the precedent for
future concepts in grafting and transplantation. Most of Hunters treatises were on
the growth and development of the teeth. His first transplantation experiment
involved a successful replacement of a premolar. The success he said, was
"founded on a disposition in all living substances to unite when brought into
contact with one
another."






of a part. He proposed in this theory: that the transplant need to
be capable of being maintained and supported by the tissues long enough to permit
revascularization. The blood he believed contained a living substance from which
all else was derived. Unfortunately, he also believed that all blood was the same
and could easily be transferred from one living animal into another. Among his
many experiments, he successfully transplanted the spur of a cock into its comb,
in an attempt to determine the influence of sex upon transplants. This type of
experiment encouraged his successors to initiate hormone research.
Hunters experiments with early organ transplants also influenced the most
significant research of Charles-Edouard Brown-Sequard (1847-1894).
Brown-Sequard received the Lacaze Prize in 1881 for his experiments on irrigation
of dying tissues by blood, suggesting that several limbs might be sewn back on.
Brown-Sequard went so far in his experiments that they were considered macabre.
An example was one in which he perfused the head of a freshly guillotined young
man with defibrinated blood in order to demonstrated how the muscles would
respond to stimulation. Variants of Hunters work were carried on by
Brown-Sequard in his grafting of tails of rats and cats into cocks combs.
Brown-Squard further extended his grafting experiments by transplanting
testes of guinea pigs into old dogs. He was so excited with the prospect of
his rejuvenation experiments on dogs, he attempted to rejuvenate himself
with self-injected extracts of testes. He measured his success by recording
the strength of the flexors of his arm.
Advances in Grafting and Transplantation
One of the major deterrents to the success of grafting was infection.
Early in the 20th century, Lister and the development of asepsis made a great
number of grafting procedures possible without infection. However another
primary problem was the complications of hemorrhage, thrombosis, and stenosis.
Developing an effective technique of vascular anastomosis to eliminate the
complications was not available until late 1946.
It was not until 1945, that the pathologist Leo Loeb formulated the
fundamental concept that tissue and organ transplantability was essentially a
search for biological identity. Loeb theorized that surgical failure in transplantation
was due to blood group agglutinable substances differing from that of organs
and tissues.
In 1930, Peter Goner identified the first histocompatibility antigen,
11
determining that isoantigenic factors are genetically present in grafted tissue and
absent in the host and are capable of eliciting a response resulting
in the
destruction of the graft.
The advent of World War II enabled Peter Medawar to give direction to the
principles of new immunology in research and transplantation. His experiments
with war wounds proposed a general theory of the nature of immunity and
"self-recognition". In 1965 Medawar wrote that
"
the success of renal homografts
in clinical practice, however meager it may be, is so very much greater than people
working in the laboratories had dared to
hope."
Medawar, after surveying this progress later said,
"
we now see what will one
day be looked back upon as the first stirrings of the science of somatic cellular





IMMUNOLOGY: THE NORMAL IMMUNE RESPONSE
Tissue Typing Procedures
Before an organ can be transplanted, the most suitable donor possible needs to be
matched to the recipient in need of the allograft. Various tests are carried out
prior to the procedure, but the most important are determining the red cell
bloodgroups, ABO, and the human leucocyte antigens HLA.
Human Leucocyte Antigen (HLA)
Originally these antigens were detected on leucocytes, but are actually present on
all cells of the body. Compatibility of these antigens between donor and recipient
is of major importance to the survival of allografts. These antigens represent part
of the major histocompatibility system (MHS) and are homologous in all mammals.
ABO Blood Grouping
Compatibility of the ABO blood group antigens of donor and recipient is
necessary for organ allografts. If a kidney is transplanted into an ABO
incompatible recipient, the antibody in the recipient combines with the
appropriate A and or B antigen on the cells of the donor kidney and will trigger
an accelerated or hyperacute rejection.
Cytotoxic Antibody Testing
Since the fluctuation of the antibody is unpredictable, study of the serum of the
recipient is necessary in a profile of their cytotoxic antibodies. This examination
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studies the production of cytotoxic anti-HLA antibody stimulated by foreign HLA
antigens encountered. Serum samples taken at regular intervals are tested in the
cytotoxic test against a panel of lymphocytes of individuals who have been
characterized and possess representatives of all the common HLA antigens. This
allows for the fluctuation in anti-HLA antibody specificity to be monitored
and enables an antibody profile to be constructed for the patient.
Tests Using Donor Cells Before Transplantation
The procedures for HLA testing differ somewhat according to whether the donor is
a living relative or a cadaver. In living related donors, it is necessary to type the
whole family for the HLA-A, B and O antigens to enable haplotypes to be deduced.
The donor of choice is an HLA-identical sibling, however, in some cases one haplo-
type similar, one haplotype different (haplo-identical) donors are accepted.
These are usually siblings, parents or offspring or the recipient.
In cadaver donors, problems may arise in lymphocyte typing.
Lymphocytes should be alive. Lymphocytes obtained from a donor who has
been on a ventilator for a long period may be moribund (dead) and contaminated.
To produce reliable results, dexamethasome is frequently administered to
potential donors with head injuries.
Crossmatch Tests
Crossmatch between the serum of the recipient and the lymphocytes of the donor
are screened within this test to show if any cytotoxic antibody is present.
Histocompatibility Matching
Histocompatibility antigens are the products of histocompatibility genes.
An antigen from one individual induces a recognition and immunological response
when presented to another member of a species who differ. Such differences
are shown to cause graft rejection.
The genetic makeup in man has led to the conclusion that one genetic
system controls strong transplantation antigens, this system is called HL-A.
Other genetic systems also exist, such as the ABO system. The less antigenic the
graft, the less the host will react against it. When donor and recipient are identical
twins and there is no antigenic difference, the tissue is accepted without
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immunosuppressive agents.
When the donor and the recipient are siblings or when a parent
donor is used, there is greater likelihood for antigen sharing between the donor
and the recipient than when a cadaver or unrelated donor is used.
The immune response to histocompatibility antigens or cells of transplanted
organs trigger the rejection response. The immune system is composed of
lymphocytes, cells of monocytes and macrophages and specialized epithelial cells.
These cells are organized into the spleen, lymph nodes, tonsils, thymus and bone
marrow. Lymphocytes and macrophages contribute to the recirculating cells found
in the blood and lymph. The thymus is essential for the development of cellular
immunity. All cells that were once dependent upon the thymus for their
development are called T cells. T cells represent the immunocompetent cell
population responsible for cellular immunity development. T cells are migratory
and must move to the periphery in order to interact with foreign antigens.
T cells are also heterogenous, offering many clones of cells each differing
from one another in structure of its antigen receptor and response. T cells
mediate important regulatory functions, they help or suppress immune
responses, including antibody production. Other T cells act as direct
destructive agents to cells bearing antigens(killer functions).
In addition, there are lymphocytes that mediate certain cytotoxic responses.
These include the natural killer (NK) cells, which recognize systems that are
different from those of T or B lymphocytes. The role of cytotoxic T cells in













PATHOLOGY OF GRAFT REJECTION
There is no doubt that allograft rejection is a specific immune response provoked
by antigenic components in the foreign tissue. The function of the graft depends
on many things other than non-specific factors, the most important single factor
in evaluating rejection is host recognition of grafted tissue as foreign and the
antigenic similarities and differences between donor and recipient. The specific
factors include preservation and quality of the donor organ, general condition of
the recipient and his original illness, and the possible development of infection.
All the above factors are important to distinguish alterations that can be attributed
to factors that are non-specific from those due to immunological graft rejection.
In recent years successful survival of grafts has been due to improvements
in preservation techniques, technical facilities, tissue typing techniques, and
better understanding of the use of immunosuppressive drugs.
The rejection reaction is thought to have three phases: the afferent arc from
allograft to donor lymphatic tissue, the central lymphoid tissue response, and the
efferent arc from the lymphatic tissues to the graft. The afferent arc consists of
recognition of foreign antigenic determinants by recipient cells and transfer of this
information to lymphoid tissues. Documentation suggests that the histocompatibil
ity antigens are released from the surfaces of graft cells into intercellular spaces
then to lymphatic and blood vessels. The antigenic matter may be in molecular
form or cellular fragments and be transported into the lymphatic system of the
host through the circulation or after being phagocytized by host macrophages.
When the antigenic matter is released it suggests that sensitization of responsive
cells could occur at a distance from the graft. There is also evidence that in-graft
sensitization also occurs and lymphoid cells pick up the antigenic stimuli
peripherally. These occurrences may exist as contact is made with specialized
passenger leucocytes of the donor organ which present graft antigens
directly to the host lymphocytes.
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The transportation by which the foreign antigens travel varies.
Afferent lymphatic channels are significant in transporting histocompatibility
antigens from the graft to the lymph nodes. Although it is clear that afferent
lymphatic are essential for the rapid destruction of allografts, the graft is
not exempt from immunological attack in their absence.
There is a definite difference between skin and organ allografts when
evaluating likelihood of rejection. This depends on several factors, the most
apparent is the size of the organ, such as the kidney. Because the kidney is large
it is able to release an effective dose of antigen into the blood, especially if it
is damaged either before or after transplantation. The kidney also has a rapid
blood flow which is restored immediately after the procedure, this factor provides
the opportunity for a vast number of host lymphocytes to react with antigen as
they travel through the vascular system of the graft.
In the central lymphoid tissue response, the involved lymphoid tissue
becomes enlarged with expanding areas of paracortical T cells. The cells become
enlarged with prominent nuclei and nucleoli and develop increased amounts of RNA
in their cytoplasm. The cells are called blast cells, lymphoblasts, activated
lymphocytes and immunoblasts.
The efferent arc phase of allograft rejection has both cellular and antibody-
mediated (humoral) components. Similar to a delayed type hypersensitivity, the
efferent arc phase shows that allograft immunity is transferable with lymphoid cells
from sensitized recipients in studies with animals. Further emphasis is given to the
realization that anti-lymphocyte globulin, which is cytotoxic to T lymphocytes, is
especially effective in suppressing delayed type hypersensitivity reactions and
allograft reaction, but appreciably less for antibody-mediated responses.
Humoral immunity plays a major role in immediate allograft rejection,
especially in patients sensitized by multiple pregnancies or blood transfusions,
and in ABO incompatible transplantation. The effects of antibodies formed after
transplantation is not clear, some contribute to rejection and others do not.
Both pre and post transplant development of allograft antibodies can lead to
successful graft survival.
Rejection of Kidney Allografts
Although most acute rejection episodes occur within the first two months following
transplantation, episodes of acute rejection both clinical and morphological, can
occur months or years after transplantation. Generally, the older the graft,
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the more likelihood of chronic changes underlying the symptoms.
Typically in rejection of transplanted kidneys, there is usually fever
present along with proteinuria and oligouria with a fall in creatinine. The kidney
will also become large and tender. Renal blood flow is often reduced.
If acute rejection is controlled and suppressed with treatment, chronic
changes become more apparent. The distinction between acute and chronic
rejection is unclear. Other changes in addition to proteinuria include a progressive
fall in creatinine clearance and a rise in serum creatinine, hypertension may
also be a concurrent finding.
Rejection of Liver Allografts
The typical pattern in early rejection of hepatic allografts is apparent when
mononuclear cells infiltrate the portal areas. As a result, the infiltrate increases
and mononuclear cells adhere to Kupffer cells and endothelial cells which line the
sinusoid of the liver. There also may be degeneration and necrosis of liver cells in
the central zones of the lobules and patches of necrosis in the periportal areas.
Often findings include intrahepatic cholestasis with bile ductules that contain
inspissated bile. The patient has fever, jaundice, and an increase in serum
trasaminase and alkaline phosphatase levels. Often distinction from infection or
biliary obstruction can be difficult and both may be present.
Livers that have survived by means of immunosuppressive therapy have
shown various amounts of fibrous tissue that bridge portal ones and portal to
central zones. The arteries frequently have stenotic lesions typical of chronic
vascular rejection Hyperacute rejection is hardly ever seen in immunosuppressed
hepatic allograft recipients, even in the presence of circulating antibody focused
against donor antigen.
Rejection of Cardiac Allografts
Signs of impaired graft functions can vary. Interstitial edema and cellular infiltration
leading to a decrease in myocardial contractility result in impaired heart sounds.
In severe rejection, signs of low cardiac output, pericardial effusion and congestive
heart failure can be evident with ECG abnormalities and arrhythmias. With severe
rejection there is increased endothelial damage, rupture of capillaries and venules
producing areas of hemorrhage, and individual myocardial fibre necrosis. In addition
occlusive vascular disease is a common occurrence in long term cardiac allografts.
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Chapter 5
U.S. SYSTEM FOR ORGAN PROCUREMENT AND TRANSPLANTATION
In 1984, the federal government funded a network for organ procurement and
transplantations, this network was established under The National Organ Transplant
Act Of 1984. The organization itself is called The United Network For Organ
Sharing (UNOS) UNOS is a private, non-profit organization that monitors the
activities and provides service to transplant centers and organ procurement
organizations (OPOS) around the nation. UNOS is also responsible for collecting
the data from transplant centers on the recipients of organ transplants.
Candidates awaiting organ transplants are placed on a central waiting list
maintained by UNOS.
At any give time, there are more than 25,000 persons on the waiting list,
and far fewer actual organ donors. Each OPO provides services related to organ
procurement, they consist of methods of referral, evaluation and surgical recovery.
In addition this system offers donor identification, management and consent,
recovery of organs, allocation, and follow-up. It is the OPO that works with the
hospital staff in determining donation potential. An organ recovery specialist seeks
consent from the next of kin, and manages the donor organ after consent has been
granted. The OPO is billed for charges relating to the donation and to the donor's
family. The OPO will then bill the cost to the transplant centers which receive
the organs for transplantation.
The role and establishment of The UNOS network
When Congress passed the National Organ Transplant Act in October of 1984, a
Task Force for Organ Procurement and Transplantation was instituted to conduct
an investigation on the medical, legal, ethical, and social aspects involved with
procurement and transplantation.
The Task force concluded that the demand for organs far exceeded the limited
supply and was due to a lack of consistency, standardization,
and regulation
within the system of procurement.
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Recommendations were then made by the Task Force in order to establish uniform
standards and uniform Determination of a Death Act legislation which would be
implemented in all states. The National Transplant Act also provided for federally
funded networks that functioned as private non-profit organizations. These
networks were composed of representations from the organ procurement
organizations (OPOs), transplant centers, voluntary health organizations, and
the general public. The contract was awarded to the United Network for Organ
Sharing (UNOS) in 1987 and served as the network necessary for organ
procurement and transplantation proceedings.
Transplant Centers
The activities and service provided to transplant centers and OPOs are regulated
and monitored by UNOS. UNOS also establishes the criteria for evaluating medical
staff qualifications of hospitals in the United States that want to perform kidney,
heart, heart-pancreas, and liver transplantations. UNOS also must approve the
hospital prior to the commencement of all transplantations. There are separate
memberships granted for each individual transplant procedure, monitored by a
quality assurance committee within UNOS.
Patients in need of transplants are referred to the transplant centers by their
private physician or transplant surgeon. The hospitals transplant coordinator then
determines an individual's eligibility based on an intensive medical and psychosocial
evaluation. Acceptance into a program is based on the extent of damage to the
failing organ system and the patient's overall health. The individual's emotional and
psychological status are also considered, as well as their ability to appreciate the
commitment involved in receiving a transplanted organ. The accepted recipients
agree to a substantial change in their lifestyle, adherence to an intense
immunosuppressive program, regular clinic visits, routine biopsies to evaluate
immune status, and coping with the potential adverse effects of the many
medications they will be on. The individual must then make a continued commit
ment to his own personal health and rehabilitation through the transplant program.
The decision to accept or reject a candidate into the program is made by the
hospitals transplant committee, composed of specialists involved in patient
management prior to the transplantation and postoperatively.
The UNOS Organ Center operates 24 hours a day to provide access to the
computerized waiting list and contains the names of
all the candidates to match
donors with the most suitable recipients. The only transplant procedure not
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regulated by UNOS is individuals who are able to receive kidney transplants
from living, related donors. However, UNOS does collect data forms submitted
by the transplant centers. These forms contain information of patient and graft
survival, immunosuppressive regimens, and the functional status of each patient.
In addition to the data collection, UNOS compiles this information and relays
it to the Department of Health and Human Services.
The system of organ procurement
Over the four past decades, there have been a list of more than 25,000 persons
awaiting organ transplants at any given time depending on the geographic region
and date of the study. In 1991, there were fewer than 5000 actual organ donors.
This scarcity of donors necessitated state and federal governments to pass a
legislation to encourage donation and remove legal barriers to the process. This
legislation was instituted as early as 1968 by the Uniform Anatomical Gift Act,
which allows an individual to make a decision regarding donation of their organs
prior to their death. By signing a donor card, an individual may specify certain
organs to donate. However, regardless of whether or not the donor card is signed,
the decedent's legal next of kin is required to give consent for donation. In order
to ensure the donation occurs, the next of kin must act as surrogate.
Unfortunately, the individual's wishes are not frequently known or expressed to the
family and the family is left to make a decision based on their understanding of
what they feel their loved one might have wanted. Another legislation passed in
1986 requires all hospitals to ensure protection of the individuals right to donate
organs and tissues. It also establishes the policies and procedures for the
identification of potential donors, and ensure the option of donation be offered
to the ideal next of kin at the time of the potential donor's death.
The eight basic components of the donation process
The actual organ donation process consists of eight basic components which
are: donor identification, referral, evaluation, consent, management,
recovery of organs, allocation, and follow-up.
Identification. Potential donors are most often victims of severe head
trauma, cerebrovascular events, or incidents of drowning or unsuccessful resuscita
tion after cardiac arrest. In each of these instances the brain has sustained an
injury that causes its complete and irreversible cessation of function, resulting in
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death of the patient. Brain death is defined by the 1980 federal uniform
Determination of Death Act as no less final than the cessation of the heart beat.
Brain dead patients have cardiovascular functions preformed by the aid of a
mechanical ventilator to assist in perfusion and oxygenation of the heart, lungs,
kidneys, liver, and pancreas. Patients who undergo primary cardiac arrest
(cardiac death) can only donate tissue. The most common tissue for donation
are heart valves, bone, skin, and cornea's.
Referral. The initial referral of a potential donor to the local OPO is made by
a physician or nurse. The recovery coordinator then investigates each referral and
the potential for donation. The coordinator is a specialist kept up to date with
criteria for donor eligibility and is a member of the heath care team. They also
assist the hospital staff in the management and care of the patient and donor.
Evaluation. This evaluation occurs by telephone to the hospital.
Data about medical history, extent of injuries, and any information about social
history are reviewed careful. Recommendations are made on the
findings, either to proceed with the consent process or to define medically
unsuitability for donation potential.
Consent. Once the family has acknowledged the death, the option of
donation is presented to them by a member of the transplant team. Concerns the
family may have about funeral arrangements and surgical procedures that may
change the outward appearance of the deceased are addressed by the team.
The family is assured that the donation will not cost them anything, all expenses
incurred while the patient was alive are billed to the responsible party, all costs
incurred after the time of death are billed directly to the OPO. The family is also
assured that the identity of the donor is kept confidential, as does that of the
recipient. If the family expresses a desire to donate only for transplantation it is
documented on the consent form, however, it is possible to place the organs for
research if they cannot be transplanted. The elements on the consent form must
be documented to make it legal. The family must specify the exact organs
and/or tissues to be donated. All potential donors must be tested for infectious
diseases. The order of legal priority to give consent for donation goes first to
the spouse, then to the adult child, the parent, sibling, legal guardian, and any
person authorized to dispose of the body. If death falls under the jurisdiction of
the medical examiners office, additional approval is needed to proceed and
that is obtained by the OPO coordinator from that office.
Management. Once all consent forms are signed, the coordinator of the
OPO writes all orders for the care of the donor. Management of the donor is a
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process that may last from 2 to 12 hours or longer and usually involves all the
hospital departments. The medical team is trained to care for the body as a
system that houses organs which will be given to others. These organs are
made to be functioning optimally prior to their removal. Often, the addition of
antimicrobials or a broad-spectrum antimicrobial such as cephalosporin is adminis
tered. Testing for infectious diseases such as cytomegalovirus, hepatitis, syphilis,
and HIV arepreformed to assure there are no contraindications to donation.
Recovery of the organs. In the operating room at the donor hospital,
surgical staff and the visiting transplant teams participate in the harvesting
process. Drugs to maintain blood pressure, oxygenation, and adequate urine
output throughout the procedure are ure utilized. Once the body is properly
prepared, the organs are each removed individually. Clamping of the aorta and
flushing of all the organs with a cold preservation solution are done simultaneously.
These solutions maintain the normal cellular osmotic gradient and arrest cellular
metabolism. The heart and lungs can be preserved for 4-6 hours , the pancreas up
to 8 hours, the liver up to 24 hours, and the kidneys up to 48 hours. The heart
and lungs are the first organs removed, followed by the pancreas, liver and kidneys.
Tissue donation which includes heart valves, skin bone, or cornea's, take place
after the organs are procured.
Allocation. Based on the variables of the donor's age, weight, height,
sex, and blood type, each organ is matched according to the national list of
potential recipients. The candidates are screened according to their blood group
and body size and are allocated according to medical urgency and time on the list.
Patients who are local have priority to receive extrarenal organs from local donors.
If there are no matches locally then the organs are sent through UNOS to the
most suitable candidate in another region. In order to increase the success of
transplantation, patients are who listed at transplant centers closer to the
donor hospital take priority over those who are located farther away. Information
about the donor is shared with the candidate's transplant surgeon. It is the
decision of the transplant surgeon to accept or reject the organ. If the organ is
accepted, the recovery teams will travel to the donor hospital for retrieval.
The local team is responsible for procuring the organ and sending it to
the transplanting center. Since the extrarenal organs deteriorate rapidly on a
cellular level, they are transplanted immediately.
Kidney allocation begins immediately after the completion of the the surgical
recovery due to a most important consideration in kidney allografts, the matching
of human leukocytic antigens (HLA) in the donor and the recipient. HLA matching
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is used only in the allocation system for kidneys. Compatibility profiles are done
prior to allocation for the recipients, according to how well their antigens match
those of the donor. Prioritization of kidney allocations are dependent on a point
system according to how well the antigens match those of the donor, the greater
the number of matching antigens the more points given to the candidate for
allocation.
Follow-up. Several types of follow-up occur once the donation process
is completed. Hospital personnel involved in the donation process are provided
general information from the OPO as to the disposition of the donor organs and
tissues. Special thanks are sent to the donor family, and they are given information
about the outcome of their gift. Support programs for donor families are offered
by many OPOs to assist the families through the grief process and to resolve




The first step involved in the donation process is referral and identification of a
potential donor to the OPO. This identification usually occurs in the emergency or
intensive care unit of the hospital. The criteria for selection of a potential donor
is kept broad to avoid any possibility of excluding a candidate. Because of the
increasing number of candidates, donor criteria are constantly changing. This
change is mainly due to improved recovery and preservation techniques, and new
immunosuppressive medication procedures. Calls are made to the local OPO for
consultation regarding donor suitability to ensure that all families are offered the
opportunity to consider the option of donation. This referral takes place as soon
as the patient's prognosis is considered terminal and irreversible. The OPO is in
operation 24 hours a day, seven days a week to respond to all inquiries and
potential donations.
When referring a potential donor to the OPO, basic information as to the
patient's name, age, sex and race are needed as well as the status of brain death
determination. In addition to these details, the family knowledge and acceptance
of the situation need to be understood. If brain death declaration is imminent, it is
stressed that a referral to an OPO does not mean a commitment to approach the
family regarding donation. The attending physician of the patient must approve
and grant permission before the donation coordinator may approach the family.
Early referral is important to prevent the situation in which the family chooses
the option of donation only to learn later that the option no longer exists for it.
The Role of the Critical Care Nurse
The Critical Care Nurse is the major link between the patient and the family in
regard to the donation process. They are usually first to identify the potential for
donation and influence attitudes about donating in the critical care setting. In
most cases the family will not identify the patient as a potential donor. The neces
sity of the nurse to offer the family the option is a crucial factor when the family
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does not have the state of mind when they are grieving to consider the option.
The Critical Care Nurse also participates in assessing of potential donors, provides
care in order to maintain and optimize function of organs, and provides support to
the family both factual and emotional. Because the nurses have a close relation
ship with the family, they are in the best position to have a positive effect on the
family in making an informed decision about the option of donation.
Donor Eligibility Screening
The donation coordinator has the first responsibility in determining a patient's
suitability for donation and begins the initial screening either at the donor hospital
or by telephone. The evaluation includes an assessment of the admitting diagnosis,
and a past medical history which includes previous hospitalization, surgeries,
and current medication. To determine medical suitability, each organ system is
reviewed separately. This assessment includes current hemodynamic status and
vasopressor history, cardiac function, urine output, ventilation status, arterial
blood gases, and a review of laboratory data.
Before the family indicates a willingness to consider donation, a
corroborating medical history of potential high-risk is assessed by the donation
coordinator. Once the family grants permission, serologic studies are performed
to rule out transmissible disease. The tests include human immunodeficiency
virus antibody, HTLV I and II antibody, hepatitis B core antibody, hepatitis C
antibody, syphilis and cytomegalovirus. Blood samples are obtained prior to any
transfusions in an ideal situation.
Determination of Brain Death
In the past the determining factor for when death occurred was based on
respiration, or lack of. However, it was discovered that respiration could be
restored if cardiac function was maintained. In the late 1950's, the forthcoming
of cardiopulmonary resuscitation brought an understanding that cardiac and
respiratory function could be restored but left organs more sensitive to
oxygen
deprivation, such as the brain, in a nonfunctional state. Scientists began to
question the traditional definition of death with this new knowledge. What was
once thought of as an indicator of death by cardiac cessation was justified by
the fact that it inevitably lead to brain death and destruction. The concept of
brain death was introduced when heart death was merely a useful index.
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In 1968, the problem of brain death received questionable attention when
Pope Pius XII called the means of sustaining life as extraordinary. He announced
that for patients who were in an irreversible coma situation, any efforts to preserve
life should not be unduly prolonged. This statement recognized that circumstances
exist where death is inevitable. As a result, and ad hoc committee was formed by
the Harvard Medical School to study the issue of brain death, thus establishing
the first criteria used for its determination.
Guidelines were established in 1981 by the President's Commission for the
Study of Bioethics in Medicine published criteria in determining death based on
complete loss of brain stem function. A special task force on Brain Death in
Children set further guidelines on brain death in pediatric patients. Since children
under 5 years of age have increased resistance to brain injury and may recover
even after exhibiting an apparent loss of brain function over longer periods of time
then adults, extended observation was deemed necessary in these patients.
The President's Commission recommends a waiting period of 6 hours
between examinations, "when the mechanism of injury is known", but advocates a
24 hour waiting period in patients with anoxic brain injury. Test such as the
electroencephalogram or cerebral perfusion scan is not required in these patients
but is recommended. In patients where the waiting period is less than 24 hours,
conditions may prevail that invalidate the usual criteria for brain death such as drug
or metabolic intoxication, hypothermia, shock, and physical immaturity. In addition,
Central nervous system depressants such as barbiturates, sedatives, and hypnotics
may produce clinical cessation of brain function. Toxicologic drug screening must
be performed when a history of drug abuse is suspected, as patients
may completely recover from the effects of drug intoxication and may not
exhibit observable signs of brain function.
Hypothermia is a condition that lowers cerebral metabolism and depresses
brain function to a point that resemble brain death, It is frequently associated with
neurologic injury and the patient must to brought back to homeostatic control
before a diagnosis of brain death can be made. Patients in shock in these
circumstances have diminished cerebral blood flow which renders the clinical
examination unreliable.
A mandatory finding for the diagnosis of brain death is apnea (cessation of
breathing). In this instance an accurate assessment of the patient's respiratory
drive is made using the apnea test as an important indicator.
Arterial blood gases
and normal hemodynamic status are necessary for an accurate apnea test.
The final determination of brain death is made by a licensed physician who is
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not a member of the organ recovery or transplant team, and this determination
much be in accordance with accepted medical criteria. Pronouncement of death
is declared when the chart includes a note stating that the patient meets all criteria
for brain death with the specific date and time. The note must be signed by the
attending physician declaring death. Once the patient is declared legally dead,
the possibility of organ donation is considered.
Considering the Option of Donation
In order for the option of donation to be successful the family must understand the
process. It is a great concern that the family's suffering not be compounded by
this approach. All effort is made by the health care professional to protect families
from further pain and suffering, in this attempt many providers of health care may
fail to offer the option of donation. As a prerequisite for helping a family through
the donation process, healthcare professionals need to evaluate their own feelings
about death and donation or organs. Approaching the family with the option of
donation begins with helping the family realize this option is offering to rather than
taking from a family in grief. The conversation is a major step to the recognition of
their loss, the initial response in the grieving process. Timing is critical and the
family has to have time to understand the hopelessness of the clinical situation.
Sensitivity to the family is vital and information about what brain death is and that
it is terminal must be clearly understood before the option of donation is offered.
Often many families may misinterpret references made during a donation
discussion in regard to the death of the patient in terms of brain death. Confusion
occurs when the family believes that the death of the brain is different from
the death of the person. Therefore, distinction between the clinical diagnosis of
brain death and the actual legal declaration of death based on the diagnosis must
be clearly understood. After sufficient time is allowed for the family to accept
the inevitability of death, they are more inclined to perceive donation as an
opportunity to create something meaningful and positive out of tragedy.
Training of the donation team is vital in dealing with grief and the donation
process so the family does not mistakenly identify those providing care for the
patient as agents for another patient who will benefit from a transplant. The
Critical Care Nurse assists by enabling family members to spend time with the
patient outside the normal hours so they can say everything that they may have
always wanted to tell the loved one in private. Family members are also allowed to
participate in the care of their love one with simple matters as assisting with a bed
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bath or combing the patient's hair. The sensitivity of the hospital staff during
this time helps to alleviate any guilt or resentment toward the hospital personnel.
The families are further assured that the donor's body will be treated with
respect and dignity during the donation process. Any questions regarding
disfigurement, funeral arrangements, or cost of the donation process is handled
by the donation coordinator. There is no cost incurred by the donor family for
participation in the donation process.
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STEPS IN THE ORGAN DONATION PROCESS
Injury or disease resulting in irreversible loss of brain and brain stem function
Identification of brain injured patient as potential organ donor
Referral to local organ procurement organization
Initial donor eligibility screening by telephone
Determination of brain death







Donor family follow-up and bereavement
support
Post donation follow-up with hospital staff
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CLINICAL CRITERIA FOR BRAIN DEATH
Irreversibility of coma established with known cause sufficient to account for
loss of all neurologic function.
Unresponsiveness to external stimuli.
Absence of spontaneous respiration in the presence of hypercarbia.
Absence of reflex activity, unless of spinal cord origin.
Absence of cephalic reflexes which include no pupillary response to light, no
eye movement with ice water calorics or doll's eye maneuver, and no gag,
cough, or corneal reflex.





In order to optimize suitability for transplantation, each organ must be evaluated
individually. This procedure ensures optimal function of each organ recovered while
maximizing the number of organs harvested. After the initial evaluation of any
potential donor
,
an accurate bedscale weight and measurement of height is taken.
For HLA testing and crossmatching, an dissection of lymph nodes are made from
the inguinal area. This will provide a proper crossmatch between donor and
potential candidates.
Renal Evaluation
The first step is to rule out a past history of renal disease, severe renal injury,
prolonged uncontrolled hypertension, family history of renal disease, prior surgery
of the kidneys, ureter or bladder, and other renal problems such as hematuria,
pyuria, proteinuria, or renal calculi. Baseline information concerning blood urea
nitrogen (BUN), peak and terminal creatinine tests about renal function are
obtained from the donors admission records. The patient's urine is analyzed for
volume and status. The flank and pelvic areas are evaluated for signs of
retroperitoneal hematomas or scars. If a peritoneal lavage or exploratory
laparotomy have been performed, the results are reviewed. To determine the
presence of proteinuria, casts, blood, or bacteria, a recent urinalysis and culture
are obtained.
Cardiac Evaluation
As with all organs, the heart evaluation begins with reviewing the
patient's medical
record to rule out a past medical history. With the heart the history is reviewed to
rule out evidence of cardiac disease, pronounced history of cardiac trauma,
rheumatic fever, family history of cardiac disease, or previous cardiac
procedures.
Events prior to hospital admission and throughout are important to document
for
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hemodynamic measurements. An prolonged periods of hypotension or bradycardia
are critically assessed. In addition, the patient is evaluated for episodes of
abnormal cardiac rate or rhythm. Any previous cardiac arrest or resuscitation
effort are thoroughly evaluated, as well as any chest injuries, cardiac contusion,
thoracic or thoracoabdominal injuries. Ideal donor heart evaluation focuses on
present heart function with normal cardiac function, however, mild abnormalities
may be present. Tests such as a 12 lead electrocardiogram are required to
determine the presence of either an old or recent myocardial infarction.
In heart donors over the age of 45, a coronary angiography is performed to assess
the presence and extent of coronary artery atherosclerotic disease. To evaluate
valvular function, ventricular wall motion, chamber size, and estimate ejection
fraction, a two dimensional echocardiogram is required. If heart function is
found to be normal following clinical evaluation, a recent history of cardiac arrest
or hypotension does not preclude heart transplantation.
Heart-Lung and Lung Evaluation
Because of the tendency for brain death and donors who are intubated, pulmonary
infections, atelectasis and other abnormalities may be present making suitable
donors for heart-lung or lung transplantation scarce. Careful attention is therefore
given to pulmonary functions, avoidance of high-inspired oxygen levels, and
excessive resusitation with fluids in potential donor patients. Family history is
assessed for documentation of chronic cough, wheezing, pallor, asthma, cyanosis,
or cardiac or pulmonary disease. Also noted are a past or present history of
tobacco use of exposure to occupational hazardous materials. In order to
document any episodes of prolonged hypotension, cardiac arrest, hypoxia, and
acid-base shifts, an evaluation of hemodynamic test results are required. A
reviewed or any previous surgery of the chest must be included, especially thoracic
or cardiac surgery. To measure the lung fields, a chest radiography is performed.
Other tests include an oxygen challenge test to measure the fraction rate of
inspired oxygen on expiratory pressure and arterial blood gases. A gram stain and
culture are obtained to discover the possible presence of polymorphonuclear
leucocytes and bacteria. The anatomy of the lungs and character of secretions are
evaluated via bronchoscopy. A complete cardiac is essential in any potential
heart-
lung donor and includes the detailed work-up specified for solely cardiac organ
donors. However, abnormal cardiac evaluation does not rule out the
potential for single or double lung transplantation.
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Liver Evaluation
In reviewing a patient's medical history for liver donation, an investigation of
chronic alcohol abuse, significant gastrointestinal disease or previous abdominal
surgery, hepatomegaly, or active blood clotting disorders as well as documented
liver disease in the patient or in their family history is carefully explored.
Assessment of hemodynamic status, hypotension, or cardiopulmonary arrest since
the time of insult or injury are well documented. Liver functional tests results are
performed and normal results are preferred, however, slight fluctuations in the
values may be acceptable. Trauma to the liver is a probable rule-out but is
evaluated on a case by case basis.
Pancreas Evaluation
The patient's medical history for pancreas donor evaluation is reviewed for
evidence of jaundice, gastrointestinal or pancreatic disease, chronic alcohol abuse,
and family history of diabetes mellitus. Tests performed as a routine part of the
evaluation include analysis of serial serum glucose and amylase.
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Chapter 8
ORGAN SHARING: AN ANSWER TO THE SHORTAGE OF ORGAN DONORS
The demand for transplantable organs far exceeds the short supply. To further
complicate the shortage, less than one-forth of potential organ donors will actually
yield an organ that is usable. Although the results of studies toward donation have
indicated strong support for the concept of transplantation, efforts to improve
the rate of recovery are necessary.
From 1988 through July 1990, a study was performed to assess the
potential for organ donation in Kentucky. The study complied data to establish the
number and location of potential donors in counties that were outside the area of
organ procurement service. All medically suitable donors referred to the procure
ment agency were discovered from an ongoing death audit. Particular focus was
placed on the process of approaching the family and the outcome of receiving
signed consent. Aspects of medical care were correlated with the timing of the
family preparation, education and approach for donation. In each aspect of the
request it was noted as to time of occurrence and the person who performed the
task. The failure to obtain permission for donation was again determined to be
the main reason for failure.
Based on timing of request for organ donation in relation with brain death,
each scenario was analyzed and classified according to two groups. When there
was a clear indication that the family understood and accepted brain death before
the discussion of organ donation occurred it was considered a decoupled situation.
Whereas in those instances in which there was no separation between the
explanation of brain death and request for donation, the criteria was consistent
with the death notice and donation request occurring simultaneously and was
then classified as being coupled.
According to the results of this study, in 1988; 23,263 deaths occurred
in
patients more than 65 years of age and 3,420 occurred outside a hospital facility.
The remaining number of deaths occurring
in the hospital were excluded based on
the presence of established contraindication for organ donation. Thus, the
potential pool of donors represented almost 3 percent of all hospital deaths which
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occurred in patients under 65 years of age. Of these one hundred and
thirty donors only 38 yielded a usable organ.
In each instance, demographic characteristics had causes of death of the
donor under consideration. Most donors were male and white. All age, race,
gender and education levels were equally represented in the potential screening.
Trauma was the leading cause of death in most of the potential donors. Objection
of the family was listed as the reason for not donating on 92 occasions in patients
who had received aggressive resuscitative efforts but succumbed within the first
few hours after arriving to the hospital. Most failures were however attributed to
the physician not identifying brain death soon enough, and not allowing the family
to be approached; or not referring a family to the organ procurement agency
after brain death occurred. In these instances, delay of the referral made donor
stability unacceptable due to rapid deterioration of the organs.
Most often it is the physician who is the person most likely to initiate the
discussion regarding donation. Many successful requests were however, the result
of the nursing service. In many instances, the consent for donation was denied by
the family. Although legislation in Kentucky showed a broad public awareness and
support for organ donation, the number actual of donations was low enough to
mandate hospitals to establish procedures which ensured families of the option
to donate when medically indicated. However, even when legislation showed in
favor of improving the donation process, it did not assure the understanding of
those in the health care system in how to best manage the request process.
This apparently was the one principal factor as to why the percentages of donation
in the state were so low.
In summary, the data showed that clear separation of the notification of
brain death and the request process had a positive influence on donation. When
request was made to a family that had accepted brain death, a donation resulted in
half of the instances. When there was not clear acceptance of death, the results
were to the contrary. The positive results of separating the brain death occurrence
from the request process was noted even when the families who had initiated the
request were removed from the comparison. Overall, the number of donors
procured in the Kentucky service area improved, this was attributable in large to
the visibility of this study within the major donor hospitals and emphasis on the
decoupling of the request process. Subsequent review of the donor request
process in 155 consecutive potential donors identified one factor that was the
most important for positive donation results; the family must have time to
understand and accept brain death before any request for donation to increase the
36
rate of positive donation procurement.
Increasing the number of organ donations.
Most European countries use "presumed
consent"
in their health care system. It
presumes that people consent to donating their organs unless they have specifical
ly objected before their death. Organs may be removed without prior consent of
the next of kin. The United States by comparison uses the system of "required
request,"
which states that the hospitals and doctors must inform patients or
their families about the option of organ donation.
Although presumed consent in European countries increased procurement
rates, the effectiveness of the system is in question in a recent trend to
ward opting for
in- legislation and away from presumed consent. In California and
England, some organizations and regions have achieved higher donation rates than
the national average. In Canada, their system is much like the United States
system of required request, their donor rates vary among provinces and
region within provinces.
What is being done to increase the donor rate? Some countries have
considered offering incentives to the donor family, some of which include financial
compensation. Other strategies have included legislative amendments for required
request and presumed consent. Other strategies particularly in the clinical setting
now include the recruitment of living donors for lung, liver and bowel transplants in
limited instances. Cadaveric donation as a means to recover organs from older
donors, "non-heart beating", and donors with diabetes, hypertension or hypoten
sion are considered in this new expanded criteria. What limits the number of
donors in intensive care units is the practice of withdrawing ventilator support from
patients when further treatment would be futile or prolonging life support until
multiorgan failure occurs.
Changes in clinical settings could increase the number of available organs.
Kidneys could be recovered from trauma patients who die soon after being
admitted to the hospital for example. Organs in non-heart beating patients could be
preserved in a perfusion technique employed shortly after pronouncement of
death. The next of kin could then be requested to donate their relative's kidneys
or tissues. In a study of this concept done in Illinois, all next of kin gave consent to
donate. In many instances, families who decide to terminate life support, the
organs could be removed immediately when the patient is pronounced dead.
Another strategy to increase the donor pool is elective ventilation. A patient dying
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as a result of a cerebrovascular accident could be given ventilation upon
respiratory arrest in an effort to preserve the organs until consent for donation
could be obtained.
Incentives
In a survey conducted by The United Network for Organ Sharing
(UNOS), incentives as a means to increase organ donation were suggested.
Half of those surveyed agreed that the incentives should be tried, The first
choice in this survey was the voluntary method to donate organs in people after
death via a donor card. This method would guarantee preferential status on a
waiting list for a transplant should they need it. Other options on the survey which
included cash incentives, were directed as financial compensation for the families
for funeral expenses or to a charity the family specified, or limited life-insurance
policies for the surviving relatives. The proposed financial compensation being a
onetime payment of $1000 or $2000. Supporters of this compensation method
suggested that donor families are not motivated by profit and hospitals are
not buying the organs but were, "rewarding the
act."
A regulated system of compensation to families does suggest that the organ
retrieval rate would increase. After all, the system is not entirely altruistic now,
Physicians, surgeons, allied health care professional, hospitals and pharmaceutical
companies gain financially from organ donation. Why should we insist on altruism
when only the donor family is expected to be altruistic? The Alternative Methods
Subcommittee of UNOS does however plan to study rewarded gifting in terms of
reimbursing funeral expenses and the preferred-status system.
According to The Canada Market Research for MORE Program of Ontario,
Toronto:
"Preferred-status"
system is not considered an ideal choice due to the
fact that many who want to donate after death fail to sign a donor card. Even
when their intent is made known, the next of kin still have to be approached
for consent.
In addition, organ allocation may change, because preferential transplants would be
given to those who have a previously signed a donor card. Potential heart and liver
recipients who do not have an alternative treatment such as dialysis would have to
wait longer. Some believe that access to transplantation would be changed if
people do not know that they must sign a donor card for preferred status. If this
situation were to occur then ethical principles such as non-discrimination and
distributive justice would be jeopardized. Furthermore, some feel that family
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compensation would undermine the ethical basis of the altruistic system. Concern
is made that families would not give consent to donate if they can trade organs, ie:
fostering the business principle of selling to the highest bidder...
The intent behind compensation or rewarded gifting is people's reluctance
to donate. High refusal rates reflect the mistrust of the health care system.
Supporters of rewarded gifting see family refusal to consent as a major barrier.
By contrast, proponents of donor compensation in other surveys (established
by UNOS), insist that the extent to which donor-family compfinsatinn is morally
objectionable has been overestimated. Supporters further concur that the entire
donation process involves payment for services rendered to every individual
apart from the donor or the family, and payment of this nature is not considered
to be morally objectionable. Therefore, the argument exists that donor-family
compensation would likely encourage more people to become donors, and concern
about the lack of altruism when financial compensation is considered is unfounded.
It is also believed that why allow thousands of people to die each each waiting
for suitable organs when compensation could lead to increased donation?
However, since there is no proof that compensation would lead to increase
in donation, this is speculative, as is the assumption that people would be
morally outraged by the proposal.
Because compensation is legally prohibited by law , and presumed-consent
would require legislation to be enacted, in the United States, support for a
well-conceived nationally funded and advocated system of equitable distribution of
organs is favored. This system would guarantee against exploitation, and benefit
the privileged and underprivileged equally. Because financial compensation is
prohibited by law in the USA, the system would include alternative methods of
compensation such as assistance in payment of funeral expenses, cash award to
the donors estate, or to their choice of charity, and a limited low cost life insurance
policy redeemable on the donation of organs by the deceased policy-holder. The
benefit of this
"non-financial"
compensation would be a "preferred-status", and
would guarantee the donor or preferential position on a waiting list should they
need an organ transplant. This preferred status would be dispensed in the form of
"extra
points"
on the UNOS points system but would not override medical urgency.
When responders of a UNOS survey were asked to rank the various forms of
compensation; preferred status was the top ranked option, followed by a $2000
payment to the donor family for funeral expenses.
If preferred status legislation were introduced in the United States, the




In the general guidelines for recipient selection, each patient is assessed individually
as a transplant candidate. There are a number of considerations that are taken
into account in the selection process. The patient should have a reasonable
life expectancy and be able to undertake the surgical intervention of the
transplant procedure.
Risk factors that would affect a successful outcome for the patient and
the transplanted kidney include contraindications which are absolute or relative
(significant). Absolute contraindications include: incurable malignancy
and infection, informed patient refusal, and refractory noncompliance.
In patients with uncured malignancy or infection, there is an extremely high
probability that these conditions will be intensified by immunosuppressive
medication, therefore making transplantation improvident.
Because some patients have psychiatric disease or mental incapacity and
will be unable to comprehend the problems or comply with the requirements
necessary for care of a successful transplantation, the potential benefits and risks
involved are thoroughly appraised and for many this procedure will not be
an option.
Relative contraindication include those factors or conditions that would
prove to be a significant increased risk, and only under unusual circumstances
would these patients be considered as suitable candidates. The patient is
considered acceptable if the relative conditions are remediable, such as coronary
bypass surgery, aortoiliac reconstruction, or construction of ileal or colonic conduit.
Age however is not considered remediable, therefore patients over age 65 are
rarely transplanted due to the cumulative effects of the aging process and poor
tolerance of immunosuppression; these patients are an operative risk.
An aging patient also has a high incidence of vascular disease which further
makes them unsuitable. Risk factors have a potentially adverse effect on outcome.
Some of these factors decrease the likelihood of graft success, many also have
a negative effect on patient survival.
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Absolute Contraindications









Renal disease with high recurrence rate
Significant Risk Factors
Age: <5 years, >45 years












Renal disease with moderate risk of recurrence
Prior malignancy
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When considering age, patients at both ends of the acceptable age range
have a decreased rate of success in transplantation. Recipients younger than 5
years of age have poor graft survival due to an increase in vascular problems,
donor selection, and rejection. However, transplantation in the pediatric patient
does has advantage by permitting for more normal growth and development
as well as psychological benefits. In the older recipient, much of the
detrimental effect accrues from increased patient mortality rather than
from unsuccessful grafting.
Each of the diseases which have systemic disease as the cause of
renal failure also have non-renal manifestations that intensify the operative
and long-term risks. Diabetic patients have increased risk factors secondary
to cardiovascular complication, poor wound healing, and decreased resistance to
infection. In patients with both primary and secondary amyloidosis the heart,
liver, gastrointestinal tract , spleen and kidneys are affected. These patients
have a higher than average post-transplantation mortality rate due to heart
failure secondary to cardiac amyloid deposition; however, most of these
patients will die of sepsis.
Fabry's disease results in the accumulation of glycosphingolipid in all the
tissues, including heart and kidneys. It is a metabolic defect which causes poor
wound healing, and sepsis. High mortality rates from this disease make
transplantation doubtful as a viable option.
Transplantation is withheld in patients with Systemic Lupus Erythematosus
until the condition is latent and anti-DNA titer are absent. Occasional reactivation
of systemic symptoms and renal recurrence have been noted in transplantation of
patients with this disease. Sclerodermia is a multisystem disease however,
mortality and success rate are considered acceptable in many reported cases.
Pre-existing Gastrointestinal Disease represents an increased risk especially
in liver disease. Advanced cirrhosis is a contraindication to renal transplantation.
Pretransplant hepatitis B increases the magnitude of the risk. Long-term survival
rate is decreased, partially owing to increased incidence of hepatic failure and
infection. Significant factors in pancreatitis, such as gallstones, hyperparathy
roidism, and alcohol intake play a role in recurrence following transplantation
and these patients frequently have a poor prognosis.
A past history of Peptic Ulcer Disease is a contraindication to trans
plantation and require careful evaluation. Recurrence of the disease in post-trans
plantation patients carries significant increase in mortality. Diverticulitis in the
transplanted patient is also accompanied by a high mortality and morbidity rate.
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If the patient has the involved colon resected prior to being considered, the rate
of successful grafting is greatly increased.
Both obesity and malnutrition have an injurious effect on would healing and
increase the potential for infection. Efforts are made prior to transplantation to
correct these conditions in order to minimize the risks.
Immunologic High Responders are identified either by the presence of a
broad antibody reactivity to the screening lymphocyte panel or by the early
rejection of a previous allograft. Graft survival in these patients is poor.
Most forms of renal disease except for congenital abnormalities have a
tendency to recur in the transplanted allograft. There are two primary reasons
disease recurs, first many patients have inadequate histologic documentation of
their original disease and prediction of recurrence in the graft may be difficult.
Second, there may be disease present in the donor organ prior to transplantation.
Ischemic injury, drug toxicity, and glomerulonephritis compound the histologic
interpretation in donor biopsies.
Prior malignancy that has been treated and cured, still imposes
an increased
risk because of the potential of immunosuppression to affect the host-tumor
interaction, permitting recurrence of metastasis.
Each patient must be individually evaluated as a potential transplant
recipient. Attempts are made to identify those factors that will determine the
operative, technical, and immunosuppressive risks. Once determined, the risks





The indications for liver transplantation differ in adults and children. Each are
grouped and considered separately according to the disease. The most common
indications for liver transplantation in adults have been chronic active hepatitis,
primary biliary cirrhosis, sclerosing cholangitis, inborn errors of metabolism, and
primary liver tumors. In children the principle indications for transplantation
include: Biliary atresia, postnecrotic cirrhosis, and inborn errors of metabolism.
B-virus antigen carriers transplanted for postnecrotic cirrhosis have a high
incidence of recurrent hepatitis after transplantation. In infants, transplantation is
complicated by a high incidence of hepatic artery thrombosis. Although liver
transplantation across ABO blood groups is usually successful, results have
been best between ABO compatible donor-recipient pairs.
When considering a patient for transplantation for primary liver cancer, it
was the hope that this particular disease would be especially favorable for trans
plantation, since portal hypertension and its complications are usually not present.
However, although early patient survival has been excellent, long term patient
survival has been poor because of the high rate of recurrence of the tumors in
immunosuppressed patients. It is found that the immunosuppression necessary to
prevent graft rejection may accelerate the growth of extrahepatic nests of
malignant cells unrecognizable at the time of transplantation. Efforts to improve
survival have included conventional chemotherapy and radiotherapy in combination
with total hepatic resection and transplantation, but results were still poor.
Cirrhosis is the most common indication for liver transplantation in adults.
Most of these patients have chronic active hepatitis, few present with cryptogenic
cirrhosis of Laennec's cirrhosis. Survival for cirrhotic patients over 40 years old is
poor, this apparently relates to the coexistence of other risk factors present in
these patients rather than the effect of age itself. For example, there is a
significant incidence or hepatitis recurrence in b-virus carriers. Alcoholic patients
have always been categorized in the high risk group, since their medical condition is
often poor and the tendency to return to their former habits is a constant concern.
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Primary biliary cirrhosis (PBC) is the second leading indication for transplan
tation in adults. This disease is uncommon and most often affects late
middle-aged women. The cause in unknown but considered to be an autoimmune
disorder. Since there is no effective medical therapy for this disorder, a sudden
increase in the rate of serum bilirubin, progression of osteoporosis, or complica
tions of portal hypertension, variceal bleeding, encephalopathy, and intractable
ascites are indications for transplantation. There have been no reported deaths or
confirmed recurrences of this disease one year post transplantation.
Sclerosing cholangitis is usually associated with other diseases, especially
inflammatory bowel disease. Increased risk of carcinoma of the bile duct often
coexists with this disease. Survival rate has been improving and risk of late
recurrence of the disease or of bile duct cancer after transplantation is not
yet known.
Inborn errors of metabolism include alpha-antitrypsin deficiency, Wilson's
disease, hemochromatosis, tyrosinemaia, and cystic fibrosis. Survival in this
group of patients has been reported with good results except for patients who
present in advanced stages of hepatic encephalopathy with acute hepatic
decompensation from Wilson's disease. The mortality rate in this instance is 50%.
Indications for transplantation in children
Biliary atresia is the most common indication for liver transplantation in children.
Most of these children have had previous operations, usually portoenterostomies
(Kasai Procedure) and portosystemic venous shunts, often with little if any
benefit. Transplantation is the only hope of long term survival in the child with
biliary atresia.
The second most common indication for liver transplantation in children
has been inborn errors of metabolism. Survival after liver replacement in these
children has been excellent. There are other indications for transplantation in
adults and children most have been done for cirrhosis, familial cholestasis,
and neonatal hepatitis.
Selection of recipients for transplantation
Most patients are evaluated and referred to the transplant center with an
established diagnosis and poor prognosis without transplantation.
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A major gastrointestinal bleed, a history of recurrent bouts of encephalopathy,
progressive neuropathy, refractory ascites, a recent precipitious deterioration
in liver function, poor hepatic synthetic function, rapid progression of bone
disease, and severe wasting are indications for early transplantation.
To assess surgical risk, a general evaluation of pulmonary, renal,
and cardiac function is performed. Portal vein patency is evaluated by ultrasound.
In selection of the donor, ultrasound measurements of the liver size are impor
tant as well as the patient's weight, height, and ABO blood group.
Cyclosporine has improved the patient survival rate and expanded
the indications for liver transplantation. Years ago, liver transplantation was
limited to patients younger than 55 years, however, survival of patients older
than 50 years in cyclosporine treated patients as been just as good as survival
for patients between 18 and 49 years of age.
Predictability of successful transplantation is based on preoperative risk
factors and is difficult to access. Patients in deep coma for example, rarely survive
unless their condition can be improved to the point that they are awake and off
the respirator when taken to surgery. Nonetheless, even patients in acute hepatic
failure and coma have survived if transplanted expediently.
Since survival is unpredictable, patients for transplantation are routinely selected
based on liver size, ABO blood group, and medical urgency. Only patients in deep,





Pancreas transplantation is restricted to patients with secondary complications
of diabetes. The procedure is performed to provide insulin replacement therapy
in Type 1 diabetes mellitus, a disease in which the beta cells within the islets
of Langerhans are destroyed by an autoimmune process.
There are more than one million insulin-dependent Type 1 diabetic patients in
the United States. The majority of the cases are in children. Diabetes mellitus is
the fourth leading cause of death by disease, the leading cause of blindness, and
the cause of 25% of all cases of renal failure. Diabetic persons are four to seven
times more likely to require an amputation and twice as likely to die of heart
disease than the rest of the general population.
Either the whole pancreas or a segment can be transplanted. Because
Diabetes mellitus is an autoimmune disease which results in destruction of the beta
cells, recurrence of the disease in the graft has been reported. In general,
however, immunosuppression prevents this occurrence.
Recipient selection and criteria for pancreas transplantation
Ideally, pancreas transplantation should be performed before the
secondary complications of diabetes are prominent. However, almost all
transplantations have been performed in patients who already display symptoms
of nephropathy, retinopathy, or neuropathy.
The effects of immunosuppession necessary to prevent rejection of these
particular complications is uncertain, as a result, most pancreas transplants are
performed in diabetic patients with end-stage diabetic nephropathy who are
undergoing or have had a kidney transplant, and in whom immunosuppressive
therapy is necessary. Because of this selection process, most pancreas transplant
patients have had such advanced complications that reversal or stabilization of the
lesion may not be possible. However, patients who do no need kidney transplants
are also considered as candidates, particularly those with preproliferative
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retinopathy and at a great risk for loss of vision.
All patients considered for pancreas transplantation undergo an evaluation
that includes the test listed below (from the University of Minnesota).
These tests are repeated at yearly intervals after transplantation to document
graft function and assess the course of secondary complications. Most important
in the evaluation process is assessment of the cardiovascular system, since
coronary artery disease may be present without angina in diabetic recipients with
neuropathy, a high incidence of myocardial infarctions have been reported in
some pancreas recipients.
Due to the side-effects of immunosuppression, pancreas transplantation has
been almost exclusively limited to adult recipients over the age of 18 years.
CRITERIA FOR PANCREAS TRANSPLANTS
At least some evidence of secondary complications (e.g., preproliferative or
background retinopathy, albuminuria).
Progressive complications, but not so far advanced as to be in a
self-perpetuating stage independent of the metabolic state.
Complications that predictably are, or will be, more serious than potential
side-effects of chronic immunosuppression.
Imperfect metabolic control on exogenous insulin.
PRE AND POST PANCREAS TRANSPLANT EVALUATION
24 hour metabolic profile
Glucose tolerance tests
Urine and serum C-peptide Stimulation with islet hormone secretogogues
Insulin withdrawal (if no history of ketosis)
Glycosylated Hb and islet cell antibodies
Neurologic evaluation:
Clinical exam, nerve conduction, autonomic tests, and quantitation of
sensory loss.
Opthalmologic evaluation:




Serum creatinine, creatinine clearance, glomerular filtration rate, renal
blood flow, sieving curve, fractional protein clearance, provocative
urinary albumin excretion, kidney biopsy.
Cardiovascular evaluation:
Stress EKG or thallium stress test, coronary arteriogram if stress test
positive or history of angina or myocardial infarct.
Camptodactyly (soft tissue) and joint evaluation:
Clinical exam, goniometry, hand prints, tracking, skin collagen
quantitation.
Psychiatric evaluation.
Pancreas transplants can be performed simultaneously with or after a kidney
transplant. Most prefer to perform simultaneous procedures utilizing transplants
from the same donor. This approach allows monitoring of the kidney for rejection,
leading to earlier diagnosis and treatment of pancreas graft rejection.
Pancreas donor selection
Two types of donors are considered in the selection process, cadaver or related
pancreas donors. Almost any brain-dead cadaver that is a suitable match for use
as kidney donor is also suitable for use as a pancreas donor if there is no prior
history of diabetes. However, brain dead cadavers that may not be acceptable
as kidney donors due to a history of kidney disease but may be suitable as
donors for pancreas and other organ transplants.
Whole or segmental pancreas grafts can be obtained from each cadaver
donor, regardless of what other organs are also procured. The same methods for
use of related donors for kidney transplants are also applied to the use of related
donors for segmental pancreas transplants. A portion of the body and tail of the
pancreas can be removed from a living donor, based on a vascular pedicle of the
splenic vessels. The spleen of the donor can survive on collateral circulation,
and the remainder of the body, head, and uncinate process of the pancreas is
sufficient to maintain normoglycemia in the donor.
Most pancreas transplants from living-related donors have necessary criteria
that the prospective living-related donors must meet before being evaluated, these
criteria are listed on the following page. Living-related donor grafts have decreased
propensity to be rejected therefore have a higher rate of successful survival.
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CRITERIA FOR SELECTION OF LIVING-RELATED PANCREAS DONORS
A. Pre-evaluation Criteria
Recipient and donor discordant for diabetes for at least 10 years.
Donor at least 10 years older than age of onset of diabetes in
recipient.




Normal oral glucose tolerance test result by criteria of Fajans and
Conn and of the Natural Diabetes Data Study Group.
Delta insulin > 90 u U/ml for sum of 0-, 60-, 120-, and 180-minute
values during cortisone-stimulated OGTT minus sum during standard
OGTT according to technique of Fajans and Conn.
*
No islet cell antibodies.
*






For patients with end-stage cardiovascular disease, cardiac transplantation
is now an accepted alternative. Considerations for cardiac transplants include:
left ventricular ejection fractions of less than 20%, and either ischemic
or idiopathic cardiomyopathy.
Absolute contraindications include: active infection, recent pulmonary
infarction, or elevation in pulmonary vascular resistance.
Relative contraindications are: diabetes mellitius, renal or hepatic
dysfunction, peripheral vascular disease, and hyperlipidemia.
Donor selection is based on no prior history of heart disease or cardiac
trauma, ABO blood group compatibility, and younger than 35 years of age.
A donor of smaller size than the recipient is taken into consideration
if there is urgency for transplantation.
Survival rates are currently one to five
years- 80 to 50%. Mortality causes
include infection, rejection, graft arteriosclerosis, and malignancy. The major cause
of patient mortality after the first year is graft arteriosclerosis, this pathogenesis is
believed to have an immunologic basis and remains an unsolved problem.
Recipient considerations
Although any patient with end-stage cardiac disease can be considered
as a potential candidate for cardiac transplantation, successful outcome is
based on many criteria.
Candidates usually have a left ventricular ejection fraction of less than 20%.
In addition to either idiopathic or ishemic cardiomyopathy. Only a small
percentage of transplant patients are considered with a history of previous
congenital heart defect or rheumatic valvular disease.
Patients with cardiac cachexia (wasting), massive edema, ascites, infections,
and renal insufficiency are considered special risks. Since the immunosuppressive
regimen necessary for successful grafting
will alter recipient immune response,
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active infection would be difficult to eradicate, thus, patients with active infection
and significantly elevated pulmonary vascular resistance may be excluded
from consideration.
Age has been a prominent factor in predicting the outcome of a
successful transplant. In the younger age groups <55 years, complications are
better tolerated and more easily treated. The average age of cardiac transplant
recipients is 38 years.
Diabetes mellitus is a major relative contraindication to cardiac transplanta
tion. Patients with diabetes that is controlled by diet or medication have an
increased likelihood for development of infection. Pulmonary infarction is another
contraindication, The sites of infection often become repositories for fungal
infection in the cardiac transplant recipient.
Other considerations which are assessed for adverse outcome are
dysfunction in other organ systems and peripheral vascular disease. The presence
of any form of peripheral vascular disease has the potential for altering the
long-term outlook. Hyperlipidemia accelerates graft coronary artery atherosclerosis
and is considered an adverse factor.
Recipient selection is a process that must include psychosocial factors
in assessing candidacy. The patient's ability to withstand the psychologic impact
of transplantation and the regimen of medication necessary post-operatively is
an important consideration in making this determination.
CONTRAINDICATIONS TO CARDIAC TRANSPLANTATION
Absolute
1 Active infection
2 Recent pulmonary infarct




2 Renal or hepatic dysfunction
3 Peripheral vascular disease
4 Hyperlipidemia
5 History of poor medical compliance






Lung transplantation has been achieved in both single lung transplantation,
bilateral lung transplantation, and combined heart-lung transplants. Patients
who have received some form of lung transplant have a reasonable expectation
for long-term survival and improved quality of life, however, to date there have
been no long-term successful lung transplants. Despite the recent advances,
many problems continue to prevent use of lung transplantation as a means
of relieving end-stage pulmonary disease.
Single lung transplants are effective in the treatment of bilateral chronic
lung diseases. In some cases of severe pulmonary insufficiency one lung is left
in place so it may ultimately recover. Use of a single lung can immediately relieve
some forms of severe pulmonary hypertension and carry the entire cardiac output.
Patients without pulmonary function in their remaining lung can survive solely
on the function of their single lung transplant.
Any procedure involving transplantation of both lungs requires a donor with
two healthy lungs and is relatively a rare occurrence.
In patients with terminal acute or chronic lung disease accompanied by
advanced cardiac disease, combined auto transplants of the heart and lungs are
considered as the procedure of choice. Studies show normal cardiopulmonary
function lasts up to 2 years post operatively. The combined procedure has
remarkable advantages in its relative technical simplicity. Improved healing of the
tracheal anastomosis, elimination of all diseased lung tissue, and the maximal
amount of functioning pulmonary parenchyma is achieved with this method.
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CONCLUSION
Since the writing of this document some disturbing concerns related to
transplantation have been expressed by the American public. These concerns were
made in regard to a few major celebrities such as: baseball star Mickey Mantle,
actor Larry Hagman, and singers Jim Nabors and David Crosby, whom have all
acquired preferential status in transplantation of donor livers. These celebrities
are over 65 years and chronic alcoholics. They are all in the high risk group for
successful survival rate. This information has raised questions and public
awareness concerning a privileged advantage involved in the decision making
process of recipient selection by the health care system.
As a writer doing research I cannot pretend to know the nature of the
legal issues that arise out of these disputes, my intent here is to simply clarify
the reasons for the donor shortage situation. If in so doing I have uncovered
any questionable practices, I apologize, with the hope that as a result of this
paper these issues that have been controversial and under public scrutiny will
ultimately become resolved.
It was my hope to increase donor participation in this thesis not to dissuade
it. However, the fact remains, certain criteria for recipient selection need to be
standardized without exception before the organ shortage can be remedied.
Several suggestions as to financial compensation and reciprocal donor contracts
have been indicated throughout this documentation. There are solutions...
Unfortunately, there does not seem to be a present solution for the inadequacy of
the American Health Care System to provide for all equally.
Until there is a time when the future looks promising for those
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